Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus
about
Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAbFiloviruses: One of These Things is (not) Like the OtherMolecular architecture of the human sperm IZUMO1 and egg JUNO fertilization complexModeling of the Ebola virus delta peptide reveals a potential lytic sequence motifAnti-Ebola therapies based on monoclonal antibodies: current state and challenges ahead.Cell entry by a novel European filovirus requires host endosomal cysteine proteases and Niemann-Pick C1.Camouflage and misdirection: the full-on assault of ebola virus diseaseHuman Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus.Three minimal sequences found in Ebola virus genomes and absent from human DNA.Molecular mechanisms of Ebola virus pathogenesis: focus on cell death.Structures of protective antibodies reveal sites of vulnerability on Ebola virus.The multiple roles of sGP in Ebola pathogenesisElucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicityA gammaherpesvirus uses alternative splicing to regulate its tropism and its sensitivity to neutralization.In silico analysis suggests interaction between Ebola virus and the extracellular matrixPossible FDA-approved drugs to treat Ebola virus infectionImproving attrition rates in Ebola virus drug discovery.Soluble Glycoprotein Is Not Required for Ebola Virus Virulence in Guinea PigsCharacterization of Immune Responses Induced by Ebola Virus Glycoprotein (GP) and Truncated GP Isoform DNA Vaccines and Protection Against Lethal Ebola Virus Challenge in MiceConsiderations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection.Towards detection and diagnosis of Ebola virus disease at point-of-care.Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus.Codon-optimized filovirus DNA vaccines delivered by intramuscular electroporation protect cynomolgus macaques from lethal Ebola and Marburg virus challengesEbola Virus Infections in Nonhuman Primates Are Temporally Influenced by Glycoprotein Poly-U Editing Site Populations in the Exposure Material.Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection.Development of a Cost-effective Ovine Polyclonal Antibody-Based Product, EBOTAb, to Treat Ebola Virus Infection.Chimeric Filoviruses for Identification and Characterization of Monoclonal AntibodiesThe lack of maturation of Ebola virus-infected dendritic cells results from the cooperative effect of at least two viral domains.Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreakGeneration of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression.Successful post-exposure prophylaxis of Ebola infected non-human primates using Ebola glycoprotein-specific equine IgG.Protein engineering strategies for the development of viral vaccines and immunotherapeutics.Characterization of host immune responses in Ebola virus infections.Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virusSmall Animal Models for Studying Filovirus Pathogenesis.Implications of Toll-like receptors in Ebola infection.Less is more: Ebola virus surface glycoprotein expression levels regulate virus production and infectivityThe roles of ebolavirus glycoproteins in viral pathogenesis.Forty Years of Ebolavirus Molecular Biology: Understanding a Novel Disease Agent Through the Development and Application of New Technologies.Host Factors Involved in Ebola Virus Replication.
P2860
Q24594601-0A9DE1A5-1084-4106-9578-925D19F8D7EEQ26783063-AB28FFD1-2E96-4344-9F02-89D34A9F42BDQ27710997-D79708F5-3D6D-4D11-A12F-FD336D5CBD06Q28651528-1B8535AA-3C45-4190-A045-B06A66C84C77Q30252022-7DC7135B-41EF-4661-AD09-AF9AC79F5457Q34443252-E1EE2FD8-98CA-4CFC-A494-CA8BC565DD69Q34449079-72AFE83E-64E7-419F-8B54-BC0CA8AD3029Q34463780-3BD54D6B-BF96-4564-B324-1DF7709C9398Q34470151-B7F64F69-0A4D-44D9-8D9C-9D434B8C6C19Q34478514-4E01B3FE-487D-4031-830B-1B021A7A1F75Q34661120-749230D8-26E3-4368-ABB3-7976A6ABF14FQ34869463-2A2B825E-A4D0-4282-8961-DFF071BF194FQ34898131-D2A89EBE-18AA-4D9D-AFCA-492E54D265B4Q35034283-4325E81F-DBD2-446D-A191-74D2DB241FF6Q35099536-56A04474-095B-4AC0-8FD6-F1747AE58DBCQ35609603-DC9A2E9D-57CB-4852-BE22-67A939FD3EA7Q35678774-8AC60214-ABDE-4AA4-8371-4CDDB53D79C1Q36043205-12B53501-4A5E-4189-AE4C-756CBDD732E7Q36043238-23EECB23-0390-49E3-9704-61CA7DF2E90EQ36043284-564F7B37-2E86-4442-ADB6-D66843DFA916Q36148222-9FD4245F-CD73-4512-BECA-41FF6D20D545Q36239796-32AC0000-0BCB-426A-8100-73CAF7159332Q36255716-1395CEB4-3E3B-446D-B59C-F11BFAAE9F5EQ36403500-F6A7D368-D663-4204-BECB-10BCE527CFFDQ36522002-F321C3A2-019F-4C8A-B6AD-718C9C5F16CBQ36654562-5D720008-45CC-4CF7-AB36-7868D71B4B8DQ36736403-77F790F5-3863-4F96-9425-B9BA7CB6C577Q36978855-2C1A5306-DB03-44CD-85AF-ABD5F778F21AQ36988908-67205D52-3217-4632-8C94-7B1DFF697B80Q37069798-3EE7DE62-B1E9-4225-8855-ECE2C5C5F03BQ37623149-3E609AA5-D3C2-4781-8AA2-B5F9698E5760Q37625877-DB52FD42-BB14-4F7F-A17A-54BEFD15CA9CQ38205274-BFBB8271-53F4-4133-8CA1-8B1B6EB2A118Q38599899-0C4508E5-EB78-4AE0-8AC7-FAEF3D294EAEQ38666317-C6F767DE-9316-428F-A663-0E75BD36EF4DQ38747644-39929358-A4D6-47D5-8250-4EFD5F460F67Q38940832-A3BD8274-FDE7-4151-9969-305CDC8C09B2Q39010678-5A38F7C7-CA09-4B9E-B65A-FBE5DCB12812Q39345592-8840504A-9337-48DD-97DC-15E7BABC49A6Q39436358-87CD2CF2-1024-4270-A076-F1D6362CAEB2
P2860
Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus
@ast
Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus
@en
Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus
@nl
type
label
Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus
@ast
Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus
@en
Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus
@nl
prefLabel
Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus
@ast
Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus
@en
Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus
@nl
P2093
P2860
P1433
P1476
Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus
@en
P2093
Chinglai Yang
Gopi S Mohan
Wenfang Li
P2860
P304
P356
10.1371/JOURNAL.PPAT.1003065
P407
P577
2012-12-13T00:00:00Z